Assignee
FERRING BV
NL·156 granted patents·86 pending applications·1,955 citations·filing 1985–2025
Top patents by PatentIndex Score
242 records- 0196US11291708B2Human-derived recombinant FSH for controlled ovarian stimulationFERRING BV·Filed 2020·Granted Apr 5, 2022·5 cites·8 claims
- 0295US5939560AInhibitors of DP-mediated processes, compositions and therapeutic methods thereofFERRING BV·Filed 1994·Granted Aug 17, 1999·253 cites·8 claims
- 0394US11260102B2Manufacture of DegarelixFERRING BV·Filed 2020·Granted Mar 1, 2022·4 cites·16 claims
- 0494US10172906B2Manufacture of DegarelixFERRING BV·Filed 2017·Granted Jan 8, 2019·11 cites·14 claims
- 0593US11826397B2Method of treating prostate cancer with GnRH antagonistFERRING BV·Filed 2022·Granted Nov 28, 2023·2 cites·11 claims
- 0693US6201132B1Inhibitors of DP-mediated processes, compositions, and therapeutic methods thereofFERRING BV·Filed 1999·Granted Mar 13, 2001·149 cites·4 claims
- 0792US10973870B2Methods of treating prostate cancer with GnRH antagonistFERRING BV·Filed 2020·Granted Apr 13, 2021·6 cites·15 claims
- 0892US10765721B2Manufacture of DegarelixFERRING BV·Filed 2018·Granted Sep 8, 2020·6 cites·19 claims
- 0992US9592266B2Manufacture of degarelixFERRING BV·Filed 2013·Granted Mar 14, 2017·11 cites·14 claims
- 1092US8022106B2Tranexamic acid formulationsFERRING BV·Filed 2009·Granted Sep 20, 2011·12 cites·57 claims
- 1192US2025296967A1Composition and method for delivery of bmp-2 amplifier/co-activator for enhancement of osteogenesisFERRING BV·Filed 2024·Application pending·0 cites
- 1291US11292824B2Pharmaceutical preparation comprising recombinant hCGFERRING BV·Filed 2019·Granted Apr 5, 2022·3 cites·6 claims
- 1391US9579359B2Method of treating prostate cancer with GnRH antagonistFERRING BV·Filed 2013·Granted Feb 28, 2017·14 cites·13 claims
- 1490US9670258B2Positive modulator of bone morphogenic protein-2FERRING BV·Filed 2016·Granted Jun 6, 2017·6 cites·4 claims
- 1590US7947739B2Tranexamic acid formulationsFERRING BV·Filed 2010·Granted May 24, 2011·14 cites·19 claims
- 1690US7947654B2Pharmaceutical formulationsFERRING BV·Filed 2009·Granted May 24, 2011·9 cites·9 claims
- 1790US7816489B2Methods for making intermediates and oxytocin analoguesFERRING BV·Filed 2007·Granted Oct 19, 2010·10 cites·9 claims
- 1890US7560429B2Orodispersible dosage forms of desmopressin acetateFERRING BV·Filed 2003·Granted Jul 14, 2009·24 cites·19 claims
- 1990US6521644B1Compositions for promoting growthFERRING BV·Filed 2000·Granted Feb 18, 2003·62 cites·16 claims
- 2089US11766468B2Method of treating prostate cancer with GnRH antagonistFERRING BV·Filed 2020·Granted Sep 26, 2023·2 cites·11 claims
- 2189US10695398B2Method of treating prostate cancer with GnRH antagonistFERRING BV·Filed 2016·Granted Jun 30, 2020·7 cites·8 claims
- 2289US10624953B2Human-derived recombinant FSH for controlled ovarian stimulationFERRING BV·Filed 2017·Granted Apr 21, 2020·6 cites·15 claims
- 2389US10526390B2Pharmaceutical preparation comprising recombinant HcGFERRING BV·Filed 2017·Granted Jan 7, 2020·6 cites·12 claims
- 2489US9579305B2Oxytocin receptor antagonist therapy in the luteal phase for implantation and pregnancy in women undergoing assisted reproductive technologiesFERRING BV·Filed 2015·Granted Feb 28, 2017·7 cites·22 claims
- 2589US5990273ASynthesis of cyclic peptidesFERRING BV·Filed 1997·Granted Nov 23, 1999·74 cites·15 claims
- 2688US11020448B2Methods comprising desmopressinFERRING BV·Filed 2018·Granted Jun 1, 2021·4 cites·13 claims
- 2788US10617644B2Composition for the treatment of fistulaFERRING BV·Filed 2017·Granted Apr 14, 2020·3 cites·17 claims
- 2888US10588926B2Lactobacillus rhamnosus bacterium for treatment of e.g. bacterial vaginosisFERRING BV·Filed 2016·Granted Mar 17, 2020·2 cites·20 claims
- 2988US9096335B2Fast dissolving pharmaceutical compositionFERRING BV·Filed 2013·Granted Aug 4, 2015·12 cites·23 claims
- 3088US6911467B2Antidiabetic agentsFERRING BV·Filed 2000·Granted Jun 28, 2005·19 cites·23 claims
- 3188US2025134948A1METHOD OF TREATING PROSTATE CANCER WITH GnRH ANTAGONISTFERRING BV·Filed 2024·Application pending·0 cites
- 3287US11673918B2Method of manufacturing a pharmaceutical compositionFERRING BV·Filed 2021·Granted Jun 13, 2023·2 cites·13 claims
- 3387US7094545B2Pharmaceutical composition as solid dosage form and method for manufacturing thereofFERRING BV·Filed 2003·Granted Aug 22, 2006·29 cites·15 claims
- 3487US7074781B2Condensed azepines as vasopressin agonistsFERRING BV·Filed 2001·Granted Jul 11, 2006·30 cites·16 claims
- 3586US12514898B2Methods of treating prostate cancer with GnRH antagonistFERRING BV·Filed 2024·Granted Jan 6, 2026·0 cites·7 claims
- 3686US9682101B2Composition for the treatment of diseaseFERRING BV·Filed 2014·Granted Jun 20, 2017·7 cites·23 claims
- 3786US7091314B2Intermediates and methods for making heptapeptide oxytocin analoguesFERRING BV·Filed 2004·Granted Aug 15, 2006·11 cites·15 claims
- 3886US7022340B2Pharmaceutical composition as solid dosage form and method for manufacturing thereofFERRING BV·Filed 2003·Granted Apr 4, 2006·30 cites·55 claims
- 3986US6214798B1GnRH antagonists being modified in positions 5 and 6FERRING BV·Filed 1998·Granted Apr 10, 2001·62 cites·20 claims
- 4086US5965701AKappa receptor opioid peptidesFERRING BV·Filed 1997·Granted Oct 12, 1999·84 cites·21 claims
- 4186US5925730AGnRH antagonistsFERRING BV·Filed 1997·Granted Jul 20, 1999·60 cites·21 claims
- 4286US5725872AComposition for foams, notably rectal foams, and foams thus obtainedFERRING BV·Filed 1996·Granted Mar 10, 1998·115 cites·64 claims
- 4385US11712422B2Pharmaceutical compositions comprising activated carbonFERRING BV·Filed 2020·Granted Aug 1, 2023·1 cites·18 claims
- 4485US10174088B2Composition and method for delivery of BMP-2 amplifier/co-activator for enhancement of osteogenesisFERRING BV·Filed 2017·Granted Jan 8, 2019·2 cites·8 claims
- 4585US9676835B2Pharmaceutical preparation comprising recombinant HcGFERRING BV·Filed 2014·Granted Jun 13, 2017·6 cites·20 claims
- 4685US7964562B2Unitary combinations of FSH and hCGFERRING BV·Filed 2007·Granted Jun 21, 2011·13 cites·7 claims
- 4784US10307459B2Pharmaceutical formulations of desmopressinFERRING BV·Filed 2018·Granted Jun 4, 2019·2 cites·15 claims
- 4884US10246499B2Composition and method for delivery of BMP-2 amplifier/co-activator for enhancement of osteogenesisFERRING BV·Filed 2014·Granted Apr 2, 2019·3 cites·16 claims
- 4984US10137167B2Methods comprising desmopressinFERRING BV·Filed 2013·Granted Nov 27, 2018·4 cites·13 claims
- 5084US7304181B2Methods for making intermediates and oxytocin analoguesFERRING BV·Filed 2006·Granted Dec 4, 2007·4 cites·20 claims
Showing the top 50 of 242 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →